Kanglong Chemical (300759.SZ) issued an advance increase. Net profit due to mother for the half-year is expected to be 729 million yuan to 772 million yuan, an increase of 4%-10% over the previous year

According to the Zhitong Finance App, Kanglong Chemical (300759.SZ) released its 2026 semi-annual results forecast. The company expects to achieve net profit attributable to shareholders of listed companies of 729 million yuan to 772 million yuan in the semi-annual period of 2026, an increase of 4%-10% over the same period last year.

In the first half of 2026, along with the continuous expansion of the company's strategic customers and the continuous advancement of the small-molecule CDMO service project pipeline, the company's new orders increased by more than 30% year-on-year; among them, new orders for laboratory services increased by more than 20% year-on-year, and new orders for small-molecule CDMO services increased by more than 50% year-on-year. The company continues to increase talent introduction efforts and expand R&D and production service teams to meet rapidly growing business needs.

The company's net profit attributable to shareholders of listed companies increased by 4%-10% compared to the same period last year under the combined influence of the continued growth of the main business, one-time adjustment expenses brought about by optimization of overseas business structures, and non-recurring profit and loss.